Rentokil 2025 Earnings: Looking Beyond The Market's Advance Praise

Rentokil Initial plc (RTO) shows stabilization in 2025, with North America organic growth improving and streamlining efforts beginning to yield results. RTO's recurring significant earnings adjustments and complex reporting continue to obscure true underlying performance, justifying a valuation discount. Leverage remains elevated at 7.5x free cash flow, and although free cash flow covers the dividend, the balance sheet is not robust.
Open original source